Recruiting
Mobile Cognitive Behavioral Therapy for Stroke
This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.
ClinicalTrials.gov IDNCT06689878
PhaseNA
Enrollment10
SponsorWeill Medical College of Cornell University
Age40 Years
SexALL
Conditions studied
Anxiety, Stroke, Depression
About this study
This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.
Interventions
- Device: Mobile CBT for Stroke — A mobile cognitive behavioral therapy (CBT) app called "Maya" that includes modules with educational content and teaching and practice of strategies that address depression and anxiety after stroke.
Primary outcomes
- Feasibility and Acceptability of MAYA as measured by the Mobile Application Rating Scale-User Version (uMARS) (Week 4 of treatment)
- Feasibility and Acceptability of MAYA as measured by the Mobile Application Rating Scale-User Version (uMARS) (Week 8 of treatment)
- Number of Sessions completed over study time period (Week 1 to Week 8 (8 week treatment))
- Qualitative Interview (Week 8 of treatment)
Eligibility information
Inclusion Criteria:
* Age 40-79
* Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation)
* Stroke that occurred 1 month or more prior to study initiation
* Capacity to provide consent
* No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study
* If taking medication for depression and/or anxiety, must be on a stable dose for a minimum of 8 weeks prior to study initiation
* Ability to use iPhone or iPad independently
* Home internet access
* Willingness to participate in the full study duration.
Exclusion Criteria:
* Aphasia of moderate or greater severity (as determined during an eligibility evaluation)
* Non-fluency in English
* History of a bipolar or psychotic disorder
* Current alcohol or substance use disorder
* Active suicidal ideation
* Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT
* Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the study doctor, which warrants a higher level of care and/or immediate referral to psychiatric services
* Any other clinical or medical reason in the study doctor's initial screening evaluation that suggests the study is not appropriate for the participant
Study locations
- Weill Cornell Medicine, New York, New York 10065 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.